All terms in BAO
| Label | Id | Description |
|---|---|---|
| adenosine A1 receptor agonist | CHEBI_65057 | |
| densitometric scan | BAO_0000464 | [Following a western analysis, the individual proteins in a gel, blot, or autoradiogram are quantitated by a densitometric scan over a limited range of protein concentration per band (1-10 ug). A scanner measures the optical density of the material by directing a beam of light and measuring its transmission or reflection.] |
| signal quantitation method | BAO_0000468 | [A digital system used for quantitating proteins in gels, blots, etc.] |
| chemiluminescence resonance energy transfer | BAO_0000462 | [Chemiluminescence resonance energy transfer (CRET) is a resonance energy transfer between chemiluminescent donors and fluorescent acceptors. CRET occurs by the oxidation of a luminescent substrate, such as luminol/hydrogen peroxide reaction catalyzed by horseradish peroxidase. CRET eliminates the disadvantages associated with donor fluorophore activation.] |
| bioluminescence resonance energy transfer | BAO_0000461 | [BRET is similar to FRET but has a bioluminescent protein such as aequorin as the donor and a fluorescent acceptor, e.g. GFP. The donor emits blue light in the absence of GFP, but when GFP and aequorin are associated as they are in vivo, GFP accepts the energy from aequorin and emits green light. Hence BRET eliminates the disadvantages associated with donor fluorophore activation.] |
| supravalvular aortic stenosis | DOID_1929 | |
| Baller-Gerold syndrome | DOID_0050654 | [A synostosis characterized by coronal craniosynostosis, short stature, and aplasia or hypoplasia of the radial bone.] |
| Williams-Beuren syndrome | DOID_1928 | |
| pseudo-TORCH syndrome 1 | DOID_0050656 | [An autosomal recessive disease that is characterized by congenital microcephaly, intracranial calcifications, severe developmental delay, severe developmental delay, simplified gyration and polymicrogyria.] |
| Gaucher's disease | DOID_1926 | [A sphingolipidosis characterized by deficiency of the enzyme glucocerebrosidase which results in the accumulation of harmful quantities of the glycolipid glucocerebroside throughout the body, especially within the bone marrow, spleen and liver.] |
| EC 3.4.21.64 (peptidase K) inhibitor | CHEBI_84297 | |
| Bamforth-Lazarus syndrome | DOID_0050655 | |
| Coffin-Siris syndrome | DOID_1925 | [A genetic disease that is characterized by underdevelopment of the tips of fingers or toes, underdevelopment or abscense of finger or toe nails and developmental disability.] |
| Bart-Pumphrey syndrome | DOID_0050658 | |
| nucleic acid conformation assessment | BAO_0000469 | [This technology relates to measurement of nucleic acid conformational properties using one of the following methods: circular dichroism spectroscopy, thermal shift, fluorescence resonance energy transfer (FRET), nuclear magnetic resonance (NMR), X-ray crystallography, etc.] |
| Bannayan-Riley-Ruvalcaba syndrome | DOID_0050657 | |
| EC 4.1.1.19 (arginine decarboxylase) inhibitor | CHEBI_65053 | |
| alternate assay format | BAO_0000467 | [This assay is performed using a different assay format with respect to the primary or confirmatory assay.] |
| biotin-responsive basal ganglia disease | DOID_0050659 | |
| Klinefelter's syndrome | DOID_1921 |